Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: a Randomized, Controlled Phase 1 Study.

Grant C PaulsenRobert FrenckKay M TomashekRodolfo M AlarconElizabeth HenselAshley LoweRebecca L BrocatoSteve A KwilasMatthew D JosleynJay W Hooper

Published in: The Journal of infectious diseases (2023)

This first-in-human candidate HPS vaccine trial demonstrated that an ANDV DNA vaccine was safe and induced a robust, durable immune response.

Keyphrases